Jiameng now ran out of excuse. nobody is believing gis b*llsh*it anymore.2019 will be the year shareholders westle back control of the company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025